Moscow, Russia. June 29, 2017. Corex Logistics, a regional leader in clinical trial logistics services has announced that its Russian depot has relocated to a much larger, state of the art facility. Built from ground up, the new 1400 square meter warehouse is a modern marble of storage excellence. It is equipped with autonomous electrical system and back-up power generators, advanced humidity and temperature control monitoring system with GSM alarm messaging, access control, 24/7 security with video surveillance, top of the line fire prevention and alarm systems, segregated areas for cytotoxic materials and quarantined products.
“The decision to move was born out of necessity,” said Serge Bordashoff, Managing Director at Corex Russia. “We were at 95% capacity at our previous location and the decision to expand was an easy one.”
The new facility was inspected by the Russian regulatory body, Roszdravnadzor and based on impeccable report received a pharmaceutical wholesaler license (# FC-99-02-005980).
The company believes that this expansion, coupled with its growing presence in Belarus, Ukraine and Georgia will help it further develop its international client base and to solidify its position as a regional frontrunner with deep local expertise.
has been in operation since 2011, has been growing steadily and has become a regional leader in clinical trial management. It offers a full range of services that include regulatory support, customs clearance, depot services, courier services, comparator sourcing and biosample management. It utilizes a proprietary Warehouse Management System, a cutting edge cloud-based software solution that allows clients to have direct access to a customized e-ordering platform with real time inventory and shipment tracking and many other imperative services. Its growing courier group operates its own fleet of vehicles with GPS tracking system and offers transportation in all temperature regimes, uses validated packaging solutions and calibrated data-loggers.
The pharmaceutical industry has faced numerous challenges since the beginning of 2021 including the rush to supply COVID-19 vaccines. The start of the year also saw the departure of the UK from the EU and theEuropean Medicines Agency (EMA). The Medicines and Healthcare Products Regulatory Agency (MHRA) is now fully in charge of all regulatory matters, oversight of clinical research and approval of medicines.
We’re here to help. Email us at firstname.lastname@example.org or use our feedback form to send us your question.